AAMC Home   Tomorrow's Doctors Tomorrow's Cures
Program Fact Sheet
    Repayment/ National Institutes of Health

Name of Program:

NIH Loan Repayment Programs (LRP)

Program Web site:


Designation (Fund Source):


Eligible Specialties:

Scientists, researchers, physicians, and other health professionals holding an M.D., Ph.D., Psy.D., Pharm. D., D.O., D.D.S., D.M.D., D.P.M., D.C., N.D., or equivalent doctoral degree from an accredited institution.

Service Requirements (formerly Service Stipulation):

NIH offers five extramural LRPs (where research is done outside of NIH at any non-profit institution); each requires a two-year commitment to conduct at least part-time research (minimum 20 hours per week average) in one of the following areas: Clinical Research, Pediatrics Research, Health Disparities Research, Contraception and Infertility Research, Clinical Research for Individuals from Disadvantaged Backgrounds. NIH offers three intramural LRPs (for NIH employees doing research at NIH); each requires a two- or three-year service commitment: General Research (3 years), AIDS Research (2 years), Clinical Research for Individuals from Disadvantaged Backgrounds (2 years)

Who Can Apply:

U.S. citizen or permanent resident with a doctoral degree (M.D., Ph.D., or equivalent; see Eligible Specialties section above) and educational loan debt equal to at least 20% of annual salary. An NIH grant is not required for participation in the NIH Loan Repayment Programs.


The FY2021 application cycle is now open. The application deadline is November 20, 2020.

Repayment/Scholarship terms:

Amount of repayment per year of service:

Each LRP repays up to $50,000 per year, plus related taxes.

How to Apply:

Visit the Application Guide on how to apply.

Additional Information/Comments:


Contact person(s):

Name, title:


Agency name:

National Institutes of Health, Division of Loan Repayment


6011 Executive Blvd, Suite 206,
Bethesda, MD 20892


(866) 849-4047


(301) 480-4802




© 1995- AAMC | 655 K Street, NW Washington, DC 20001 |  Contact Us |  Follow Us  |  Terms and Conditions  |  Privacy Statement